Evidence map›Paper›PMID 39561104›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2024

Long-duration type 1 diabetes is associated with deficient cortical bone mechanical behavior and altered matrix composition in human femoral bone.

Shannon R Emerzian, Jarred Chow, Ramina Behzad, Mustafa Unal, Daniel J Brooks, I-Hsien Wu, John Gauthier, Surya Vishva Teja Jangolla, Marc Gregory Yu, Hetal S Shah and 5 more

Abstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Differences and similarities in cortical bone of the femur between donors with and without type 2 diabetes.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  2. Contributions of Bone Microarchitecture to Skeletal Fragility in Adults with Longstanding Type 1 Diabetes.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Recent Updates on Diabetes and Bone.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Bone microstructure and TBS in diabetes: what have we learned? A narrative review.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shannon R EmerzianCenter for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.ORCID 0000-0002-1085-4128
Jarred ChowCenter for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
Ramina BehzadDepartment of Bioengineering, University of Massachusetts Dartmouth, Dartmouth, MA 02747, United States.
Mustafa UnalCenter for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.ORCID 0000-0002-9518-8952
Daniel J BrooksCenter for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
I-Hsien WuResearch Division, Joslin Diabetes Center, Boston, MA 02215, United States.
John GauthierResearch Division, Joslin Diabetes Center, Boston, MA 02215, United States.
Surya Vishva Teja JangollaResearch Division, Joslin Diabetes Center, Boston, MA 02215, United States.
Marc Gregory YuResearch Division, Joslin Diabetes Center, Boston, MA 02215, United States.
Hetal S ShahResearch Division, Joslin Diabetes Center, Boston, MA 02215, United States.
George L KingResearch Division, Joslin Diabetes Center, Boston, MA 02215, United States.
Fjola JohannesdottirCenter for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
Lamya KarimDepartment of Bioengineering, University of Massachusetts Dartmouth, Dartmouth, MA 02747, United States.
Elaine W YuDepartment of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
Mary L BouxseinCenter for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Translational Researchin Aging Trainnig ProgramT32AG023480 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI LIPSITZ, LEWIS · 2004 to 2024
$7.6M
Translational Imaging and Phenotyping CoreP30AR075042 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI MARY L BOUXSEIN, PAOLA DIVIETI PAJEVIC · 2019 to 2026
$7.4M
Delineating mechanisms of skeletal fragility in older adults with Type 1 DiabetesR01DK124710 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI YU, ELAINE WEI-YIN · 2021 to 2025
$4.8M
Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetesR01HL161864 · NHLBI · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 2022 to 2025
$3.2M
Identification of Retinoid-Binding Protein 3 (RBP3): A Protective Factor against Diabetic Retinopathy Using Retina from People with Extreme Duration of DiabetesR01EY026080 · NEI · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 2016 to 2024
$3.1M
Biomechanical mechanisms underlying skeletal fragility in older adults with Type 1 diabetesR56DK122593 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BOUXSEIN, MARY L, YU, ELAINE WEI-YIN · 2019 to 2020
$616k
NEI NIH HHS R01 EY026080NHLBI NIH HHS R01 HL161864NIAMS NIH HHS P30 AR075042NIA NIH HHS T32 AG023480NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK124710NIDDK NIH HHS R56 DK122593NIH HHS HL161864
6 · The paper itself

Abstract

Type 1 diabetes (T1D) is associated with an increased risk of hip fracture beyond what can be explained by reduced bone mineral density, possibly due to changes in bone material from accumulation of advanced glycation end-products (AGEs) and altered matrix composition, though data from human cortical bone in T1D are limited. The objective of this study was to evaluate cortical bone material behavior in T1D by examining specimens from cadaveric femora from older adults with long-duration T1D (≥50 yr; n = 20) and age- and sex-matched nondiabetic controls (n = 14). Cortical bone was assessed by mechanical testing (4-point bending, cyclic reference point indentation, impact microindentation), AGE quantification [total fluorescent AGEs, pentosidine, carboxymethyl lysine (CML)], and matrix composition via Raman spectroscopy. Cortical bone from older adults with T1D had diminished postyield toughness to fracture (-30%, p = .036), elevated levels of AGEs (pentosidine, +17%, p = .039), lower mineral crystallinity (-1.4%, p = .010), greater proline hydroxylation (+1.9%, p = .009), and reduced glycosaminoglycan (GAG) content (-1.3%, p < .03) compared to nondiabetics. In multiple regression models to predict cortical bone toughness, cortical tissue mineral density, CML, and Raman spectroscopic measures of enzymatic collagen crosslinks and GAG content remained highly significant predictors of toughness, while diabetic status was no longer significant (adjusted R2 > 0.60, p < .001). Thus, the impairment of cortical bone to absorb energy following long-duration T1D is well explained by AGE accumulation and modifications to the bone matrix. These results provide novel insight into the pathogenesis of skeletal fragility in individuals with T1D.

Indexed as

Cortical BoneDiabetes Mellitus, Type 1FemurGlycation End Products, AdvancedAgedArginineBiomechanical PhenomenaBone DensityBone MatrixFemaleHumansLysineMaleMiddle AgedSpectrum Analysis, RamanTime FactorsArginineGlycation End Products, AdvancedLysinepentosidinebiomechanicsbone compositioncortical bonefractureRaman spectroscopytoughnesstype 1 diabetes

Identifiers

PMID39561104
PMCPMC11700620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.